BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 38517693)

  • 21. DGHNE: network enhancement-based method in identifying disease-causing genes through a heterogeneous biomedical network.
    He B; Wang K; Xiang J; Bing P; Tang M; Tian G; Guo C; Xu M; Yang J
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36151744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Mirna-Disease Associations Based on Neighbor Selection Graph Attention Networks.
    Zhao H; Li Z; You ZH; Nie R; Zhong T
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):1298-1307. PubMed ID: 36067101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. dbDEMC 3.0: Functional Exploration of Differentially Expressed miRNAs in Cancers of Human and Model Organisms.
    Xu F; Wang Y; Ling Y; Zhou C; Wang H; Teschendorff AE; Zhao Y; Zhao H; He Y; Zhang G; Yang Z
    Genomics Proteomics Bioinformatics; 2022 Jun; 20(3):446-454. PubMed ID: 35643191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting miRNA-disease associations via learning multimodal networks and fusing mixed neighborhood information.
    Lou Z; Cheng Z; Li H; Teng Z; Liu Y; Tian Z
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35524503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-target affinity prediction using graph neural network and contact maps.
    Jiang M; Li Z; Zhang S; Wang S; Wang X; Yuan Q; Wei Z
    RSC Adv; 2020 May; 10(35):20701-20712. PubMed ID: 35517730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directed graph attention networks for predicting asymmetric drug-drug interactions.
    Feng YY; Yu H; Feng YH; Shi JY
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35470854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting miRNA-disease associations via layer attention graph convolutional network model.
    Han H; Zhu R; Liu JX; Dai LY
    BMC Med Inform Decis Mak; 2022 Mar; 22(1):69. PubMed ID: 35305630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying drug-target interactions via heterogeneous graph attention networks combined with cross-modal similarities.
    Jiang L; Sun J; Wang Y; Ning Q; Luo N; Yin M
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35224614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hierarchical graph attention network for miRNA-disease association prediction.
    Li Z; Zhong T; Huang D; You ZH; Nie R
    Mol Ther; 2022 Apr; 30(4):1775-1786. PubMed ID: 35121109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SGNNMD: signed graph neural network for predicting deregulation types of miRNA-disease associations.
    Zhang G; Li M; Deng H; Xu X; Liu X; Zhang W
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34875683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting drug-drug interactions by graph convolutional network with multi-kernel.
    Wang F; Lei X; Liao B; Wu FX
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of pairwise neighbor topologies and miRNA family and cluster attributes for miRNA-disease association prediction.
    Xuan P; Wang D; Cui H; Zhang T; Nakaguchi T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34634106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A graph auto-encoder model for miRNA-disease associations prediction.
    Li Z; Li J; Nie R; You ZH; Bao W
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 34293850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep-belief network for predicting potential miRNA-disease associations.
    Chen X; Li TH; Zhao Y; Wang CC; Zhu CC
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 34020550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDA-GCNFTG: identifying miRNA-disease associations based on graph convolutional networks via graph sampling through the feature and topology graph.
    Chu Y; Wang X; Dai Q; Wang Y; Wang Q; Peng S; Wei X; Qiu J; Salahub DR; Xiong Y; Wei DQ
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34009265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMCMDA: neural multicategory MiRNA-disease association prediction.
    Wang J; Li J; Yue K; Wang L; Ma Y; Li Q
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33778850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GraphDTA: predicting drug-target binding affinity with graph neural networks.
    Nguyen T; Le H; Quinn TP; Nguyen T; Le TD; Venkatesh S
    Bioinformatics; 2021 May; 37(8):1140-1147. PubMed ID: 33119053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CIPHER-SC: Disease-Gene Association Inference Using Graph Convolution on a Context-Aware Network With Single-Cell Data.
    Zhang Y; Chen L; Li S
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):819-829. PubMed ID: 32809944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variational graph auto-encoders for miRNA-disease association prediction.
    Ding Y; Tian LP; Lei X; Liao B; Wu FX
    Methods; 2021 Aug; 192():25-34. PubMed ID: 32798654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graph Convolutional Autoencoder and Generative Adversarial Network-Based Method for Predicting Drug-Target Interactions.
    Sun C; Xuan P; Zhang T; Ye Y
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(1):455-464. PubMed ID: 32750854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.